2025-2034 Growth Prospects of the Cardiac Rhythm Management (CRM) Devices And Equipment Market: Key Trends and Opportunities Analyzed
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Significant is the Anticipated Growth Rate of the Cardiac Rhythm Management (CRM) Devices And Equipment Market from 2025 to 2034?
The market for cardiac rhythm management (CRM) devices and equipment has seen robust growth in the past years. It is projected to escalate from $16.05 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. The past growth can be credited to factors like the commonality of arrhythmias, advancements in technology, an aging population, and the management of chronic diseases.
Anticipated robust growth is on the horizon for the cardiac rhythm management (CRM) devices and equipment market. By the year 2029, its value is projected to reach $21.73 billion, progressing at a compound annual growth rate (CAGR) of 6.1%. The expansion during the forecast period can be linked to advancements in personalized medicine, technological innovation, the integration of telehealth, and increased worldwide access to healthcare. Key trends expected to emerge during this forecast period encompass developments like leadless CRM devices, biodegradable devices, remote monitoring, and combination therapies.
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Cardiac Rhythm Management (CRM) Devices And Equipment Market?
The cardiac rhythm management (CRM) devices and equipment market is anticipated to grow, powered by the escalating geriatric population. This term refers to individuals who are 65 years old or older. As this population segment enlarges, so does the occurrence of cardiovascular diseases, leading to a higher demand for CRM devices. Such devices are beneficial in addressing heart rhythm disorders like arrhythmias, enhancing the life quality of the elderly. For example, the Administration for Community Living, a governmental department in the US, reported that the older population totalled 55.8 million in 2021. Projections indicate that this figure will rise to 80.8 million by 2040 and further increase to 94.7 million by 2060. Consequently, the escalating geriatric population is fuelling the growth of the cardiac rhythm management (CRM) devices and equipment market.
Request Your Free Cardiac Rhythm Management (CRM) Devices And Equipment Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2548&type=smp
Who Are the Dominant Players Pushing the Boundaries of the Cardiac Rhythm Management (CRM) Devices And Equipment Market?
Major companies operating in the cardiac rhythm management (CRM) devices and equipment market include Abbott Laboratories, Medtronic plc, Biotronik SE & Co KG, Cardiac Science Corporation, Schiller AG, Hill-Rom Holdings Inc., GE Healthcare, Integer Holdings, Neovasc Inc., Philips Healthcare, Stryker Corporation, Rochling Medical, CCC Medical Devices, LivaNova plc, ZOLL Medical Corporation, Koninklijke Philips N.V, Applied Cardiac System, Cook Medical, Abiomed Inc., Berlin Heart GmbH, Brotionik SE and Co. KG, Jarvik Hearth Inc., MicroPort Scientific Corp, ReliantHeart Inc., Shree Pacetronix Ltd., Shaanxi Qinming Medical Instrument Co. Ltd., AtriCure Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, ProgettiSrl
How Are Market Trends Revolutionizing the Cardiac Rhythm Management (CRM) Devices And Equipment Industry in Recent Times?
Key businesses in the Cardiac Rhythm Management (CRM) devices and equipment landscape are enhancing their product offerings with innovations such as single-chamber (VR) leadless pacemakers to effectively navigate heart rhythm complications and enhance patient results. The leadless pacemaker, which is inserted directly into the right ventricle of the heart through a minimally intrusive surgery, eradicates the requirement for cardiac leads. In one exemplification of this trend, Abbott Laboratories, a US-domiciled medical equipment organization, gained FDA endorsement in April 2022 for its Aveir single-chamber (VR) leadless pacemaker, designed to provide a treatment option for individuals experiencing slow heart rhythms. The device not only provides extensive data on patient health and cardiovascular activity to assist in making treatment choices, but its Aveir VR leadless pacemaker software has been purposely developed to accommodate an upgrade to a dual-chamber system, potentially paving the way for more comprehensive treatment alternatives for patients down the line.
Pre-order Your Report for Quick and Easy Delivery!
Which Primary Segments of the Cardiac Rhythm Management (CRM) Devices And Equipment Market Are Driving Growth and Industry Transformations?
The cardiac rhythm management (CRM) devices and equipment market covered in this report is segmented –
1) By Product: Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT)
2) By Application: Bradycardia, Tachycardia, Heart Failure, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Physicians Clinics
Subsegment:
1) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Implantable Pacemakers
2) By Defibrillators: Implantable Cardioverter Defibrillators (ICDs), External Defibrillators, Wearable Defibrillators, Automated External Defibrillators (AEDs)
3) By Cardiac Resynchronization Therapy (CRT): CRT-P (Pacemaker), CRT-D (Defibrillator), Bi-Ventricular Pacemakers
Which Geographic Areas Are Influencing the Growth of the Cardiac Rhythm Management (CRM) Devices And Equipment Market?
North America was the largest region in the global cardiac rhythm management (CRM) devices and equipment market in 2023. Western Europe was the second-largest region in the cardiac rhythm management (CRM) devices and equipment market. The regions covered in the cardiac rhythm management (CRM) devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Are the Core Features That Define the Cardiac Rhythm Management (CRM) Devices And Equipment Market?
Cardiac rhythm management (CRM) devices and equipment are used to manage the heart rate or rhythm by generating electrical impulses or shocks in order to get the heart back to its normal functions. CRM devices are used to treat and manage arrhythmia-related diseases such as cardiac arrests, heart failure, or cardiac arrhythmias.
Browse Through More Similar Reports By The Business Research Company:
Medical Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report
Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024
Cardiovascular Medical Lasers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-medical-lasers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
